IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c<sup>hi</sup>T-bet<sup>+</sup> B cells in SLE.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29717110.
- Also identified by DOI 10.1038/s41467-018-03750-7 and PMC identifier 5931508.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Although the aetiology of systemic lupus erythematosus (SLE) is unclear, dysregulated B cell responses have been implicated. Here we show that an unusual CD11c<sup>hi</sup>T-bet<sup>+</sup> B cell subset, with a unique expression profile including chemokine receptors consistent with migration to target tissues, is expanded in SLE patients, present in nephrotic kidney, enriched for autoreactive specificities and correlates with defined clinical manifestations. IL-21 can potently induce CD11c<sup>hi</sup>T-bet<sup>+</sup> B cells and promote the differentiation of these cells into Ig-secreting autoreactive plasma cells. While murine studies have identified a role for T-bet-expressing B cells in autoimmunity, this study describes and exemplifies the importance of CD11c<sup>hi</sup>T-bet<sup>+</sup> B cells in human SLE.
Medical subject headings
- B-Lymphocytes
- CD11c Antigen
- Cell Differentiation
- Interleukins
- Lupus Erythematosus, Systemic
- Plasma Cells
- T-Box Domain Proteins